Search results
Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia
Digital Journal· 19 hours agoVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 17, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at developments ...
Blincyto Picks Up New BCP-ALL Indication
Medscape· 3 hours agoThe agent is the first BiTE approved for consolidation regardless of MRD status.
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Zacks via Yahoo Finance· 4 days agoShattuck (STTK) will now focus on higher-risk myelodysplastic syndromes and TP53 mutant acute ...
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology...
Digital Journal· 4 days agoTUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
The West Side Index & Gustine Press-Standard· 4 days ago- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, including those receiving prior venetoclax
Why Is Bio-Path (BPTH) Stock Up 20% Today?
InvestorPlace· 4 days agoBio-Path (NASDAQ:BPTH) stock is rising higher on Friday alongside data from the oncology-focused company’s Phase 2 clinical trial of prexigebersen....
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 4 days agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Digital Journal· 1 day agoOperations Update LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its
Educational Development Corporation Announces Executed Fifth Amendment to Credit Agreement
Digital Journal· 11 hours ago...Partners with National Cyber Security to Provide Cyber Protection for Homeowners Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML) CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment Atlas Lithium Doubles the Size...
Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 191.7% in May
ETF DAILY NEWS· 5 days agoDominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,500 ...
